0001209191-18-055413.txt : 20181017
0001209191-18-055413.hdr.sgml : 20181017
20181017180942
ACCESSION NUMBER: 0001209191-18-055413
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181015
FILED AS OF DATE: 20181017
DATE AS OF CHANGE: 20181017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haag-Molkenteller Cornelia
CENTRAL INDEX KEY: 0001748297
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38667
FILM NUMBER: 181127173
MAIL ADDRESS:
STREET 1: C/O UROVANT SCIENCES, INC.
STREET 2: 5151 CALIFORNIA AVENUE, SUITE 250
CITY: IRVINE
STATE: CA
ZIP: 92617
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Urovant Sciences Ltd.
CENTRAL INDEX KEY: 0001740547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5151 CALIFORNIA AVENUE
STREET 2: SUITE 250
CITY: IRVINE
STATE: CA
ZIP: 92617
BUSINESS PHONE: 949-226-6029
MAIL ADDRESS:
STREET 1: 5151 CALIFORNIA AVENUE
STREET 2: SUITE 250
CITY: IRVINE
STATE: CA
ZIP: 92617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-15
0
0001740547
Urovant Sciences Ltd.
UROV
0001748297
Haag-Molkenteller Cornelia
C/O UROVANT SCIENCES, INC.
5151 CALIFORNIA AVENUE, SUITE 250
IRVINE
CA
92617
0
1
0
0
CMO of Urovant Sciences, Inc.
Stock Option (Right to Buy)
13.65
2018-10-15
4
A
0
1000
0.00
A
2028-10-14
Common Shares
1000
1000
D
25% of the total shares underlying the option shall vest and become exercisable on October 1, 2019; the remaining shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
/s/ John T. McKenna, Attorney-in-Fact
2018-10-17